Live Breaking News & Updates on Stemcell Asc Inc

Stay updated with breaking news from Stemcell asc inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Global Induced Pluripotent Stem Cell (iPS Cell) Industry


Global Induced Pluripotent Stem Cell (iPS Cell) Industry Report 2021: Methods of Commercializing iPSCs are Diverse and Continue to Expand
April 13, 2021 06:13 ET
| Source:
Research and Markets
Research and Markets
Dublin, IRELAND
ResearchAndMarkets.com s offering.
The main objectives of this report are to describe the current status of iPSC research, patents, funding events, industry partnerships, biomedical applications, technologies, and clinical trials for the development of iPSC-based therapeutics.
Since the discovery of induced pluripotent stem cells (iPSCs) a large and thriving research product market has grown into existence, largely because the cells are non-controversial and can be generated directly from adult cells. It is clear that iPSCs represent a lucrative market segment because methods for commercializing this cell type are expanding every year and clinical studies investigating iPSCs ....

United States , James Thomson , Takara Bio , Biocat Gmb , Waisman Biomanufacturing , Cellgenix Gmb , Shinya Yamanaka , Masayo Takahashi , Promocell Gmb , Cell Biolabs Inc , Metrion Biosciences Ltd , Categories Of Research Publications , Fate Therapeutics Inc , Beckman Coulter Life Sciences , Pscs Technology , Rd Systems Inc , Bluerock Development Agreement , Takeda Pharmaceutical Co Ltd , Xcell Science Inc , Corning Inc , Thermo Fisher Scientific Inc , Gentarget Inc , Biotechnology Europe Ltd , Stemcell Asc Inc , Lonza Group Ltd , Vistagen Therapeutics Inc ,

Global Induced Pluripotent Stem Cell (iPS Cell) Market Report 2021: In Total, At Least 68 Distinct Market Competitors Now Offer Various Types of iPSC Products, Services, Technologies and Therapies


Share this article
Share this article
ResearchAndMarkets.com s offering.
The main objectives of this report are to describe the current status of iPSC research, patents, funding events, industry partnerships, biomedical applications, technologies, and clinical trials for the development of iPSC-based therapeutics.
Since the discovery of induced pluripotent stem cells (iPSCs) a large and thriving research product market has grown into existence, largely because the cells are non-controversial and can be generated directly from adult cells. It is clear that iPSCs represent a lucrative market segment because methods for commercializing this cell type are expanding every year and clinical studies investigating iPSCs are swelling in number. ....

United States , James Thomson , Takara Bio , Biocat Gmb , Waisman Biomanufacturing , Cellgenix Gmb , Shinya Yamanaka , Masayo Takahashi , Promocell Gmb , Laura Wood , Cell Biolabs Inc , Metrion Biosciences Ltd , Categories Of Research Publications , Fate Therapeutics Inc , Beckman Coulter Life Sciences , Pscs Technology , Rd Systems Inc , Bluerock Development Agreement , Takeda Pharmaceutical Co Ltd , Office Hours Call , Xcell Science Inc , Corning Inc , Thermo Fisher Scientific Inc , Gentarget Inc , Biotechnology Europe Ltd , Stemcell Asc Inc ,